AMLODAC T is a combination of Amlodipine and Telmisartan which belongs to a group of medicines called Antihypertensives. It is used to treat high blood pressure. High blood pressure (also known as hypertension) is a medical condition in which the force of the blood exerted against the walls of the artery remains very high, and as a result it may lead to severe damage to the blood vessels of several organs, thus causing heart attack, heart or kidney failure, stroke, or even blindness.
Amlodipine is a Calcium channel blocker and Telmisartan is an Angiotensin-II antagonist. Collectively, they act together and reduces blood pressure by relaxing the blood vessels supplying the heart, thus making it easier for your heart to pump blood around your body.
Before taking AMLODAC T inform your doctor if you have diabetes, low blood pressure, heart diseases and liver or kidney problems. AMLODAC T is generally not recommended for use in pregnant women and in children (below 18 years). Consult your doctor before taking. Avoid grapefruit juice while taking AMLODAC T as it may cause unwanted interactions. The common side effects of AMLODAC T are dizziness, swelling in the ankle, tiredness, headache or upset stomach.
AMLODAC T effectively reduces blood pressure, where amlodipine acts by reducing the contractility of the heart muscles and telmisartan acts by blocking the actions of a peptide called Angiotensin – II, which is responsible for increasing blood pressure. Collectively, they relax the blood vessels supplying the heart, thus making it easier for your heart to pump blood around your body.
Take AMLODAC T with or without food. Swallow it as a whole and do not crush or chew the medicine. Do not stop taking AMLODAC T unless advised by your doctor.
Stop taking AMLODAC T and contact your doctor immediately if you experience any of the following side effects:
Headache:
Rest and drink plenty of fluids. Apply a wet or cold cloth to forehead and rest in a quiet, comfortable, dark room.
Constipation:
Take fiber rich foods in your diet such as fresh fruits, vegetables and whole grain cereals, and drink plenty of fluids. Exercise more regularly and stay active.
Nausea:
Try to take this medicine with, or just after, a meal or snack and stick to simple meals and do not eat oil rich or spicy food.
AMLODAC T is not recommended in early pregnancy and must not be taken after the third month of pregnancy, as it may cause serious harm to your baby. Consult your doctor for advice.
AMLODAC T may pass into breast milk in small amounts, hence it should be used with caution during breastfeeding. Consult your doctor for advice.
Do not drive or operate any tools or machines if you experience dizziness, fainting or spinning sensation while taking AMLODAC T.
Avoid consumption of alcohol while taking AMLODAC T as it may make you feel dizzy.
AMLODAC T should be used with caution in patients with kidney disease (renal artery stenosis). Consult your doctor for advice.
AMLODAC T should be used with caution if you have liver disease (biliary obstruction). Consult your doctor for advice.
Tell your doctor if you are allergic to Amlodipine or Telmisartan or any other ingredients of AMLODAC T.
AMLODAC T is not recommended for use in patients with recent heart attack, aortic stenosis, cardiogenic shock, heart failure and should be used with caution in patient’s having unstable angina. Consult your doctor for advice.
Inform your physician before taking AMLODAC T if you have or had,
Use in pediatrics:
AMLODAC T is not recommended for use in children and adolescents less than 18 years of age. Consult your doctor for advice
Use in geriatrics:
AMLODAC T should be used with caution in elderly patients particularly at higher doses. Consult your doctor for advice.
A. Drug-Drug interactions:
Before taking AMLODAC T, inform your doctor if you are taking:
B. Drug-Food interactions:
Do not eat grapefruit or drink grapefruit juice while taking AMLODAC T as it increases the level of this medicine in the blood resulting in lower blood pressure than desired. Consult your doctor before taking it.
Overdosage:
If you or anyone else accidentally take too much of AMLODAC T, consult your doctor immediately. Overdosage can cause severe low blood pressure such as fainting, dizziness, weakness and increase in heartrate.
Drug | : | Amlodipine, Telmisartan |
Pharmacological Category | : | Calcium channel blockers, Angiotensin-II receptor blockers |
Therapeutic Indication | : | High blood pressure |
Dosage Forms | : | Tablet |
What will happen if I stop taking AMLODAC T?
You should not stop taking AMLODAC T without talking to your doctor first as it may increase the blood pressure.
Is it safe to take AMLODAC T for a long time?
Yes, it is safe to take AMLODAC T for long time, if advised by your doctor. Your doctor will determine the dose and duration of treatment depending upon the condition and response to the treatment in managing your blood pressure.
What happens if I forget to take AMLODAC T?
If you miss a dose taking AMLODAC T, take it as soon as you remember and do not double the dose.
How can I effectively control my blood pressure while taking AMLODAC T?
Your doctor may generally advice you to do regular physical exercises, lifestyle changes and dietary changes, especially salt restricted diet. Reducing stress will effectively help in controlling blood pressure rather than taking AMLODAC T alone.
Can I take AMLODAC T before driving?
Do not take AMLODAC T before driving as it can cause side effects such as dizziness, sleepiness, vertigo, or tiredness. If this is a matter of concern, consult your doctor for alternative medicines.
1. KD Tripathi MD. Antihypertensive drugs. Essentials of Medical Pharmacology 7th ed. New Delhi, May 2013. Page – 561.
2. Jaswant Goyal, Zafer Yab Khan, Prerna Upadhyaya, Barkha Goyal and Shipra Jain. Comparative Study of High Dose Monotherapy of Amlodipine or Telmisartan, and Their Low Dose Combination in Mild to Moderate Hypertension. June 20, 2014. [Accessed on 23rd March 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129356/
3. Telmisartan/Amlodipine Alembic. [Accessed on 23rd March 2022] https://mri.cts-mrp.eu/Human/Downloads/EE_H_0301_003_FinalPL.pdf
4. Actavis Ltd. Electronic Medicines Compendium (EMC). [Revised in July 2021] [Accessed on 23rd March 2022] https://www.medicines.org.uk/emc/files/pil.12400.pdf
5. Dr. Reddy’s Laboratories (UK) Ltd. Electronic Medicines Compendium (EMC). [Revised in August 2018] [Accessed on 23rd March 2022] https://www.medicines.org.uk/emc/files/pil.3478.pdf
6. Sanofi India Limited. Windlas Biotech Private Limited. [Revised on July, 2019] [Accessed on 23rd March 2022] https://www.sanofi.in/-/media/Project/One-Sanofi-Web/Websites/Asia-Pacific/Sanofi-IN/Home/science-and-innovation/for-healthcare-professionals/product-information/Telsite-am-PI-June-2018.pdf?la
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.